Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Epigenetic editing approaches maturity: AI-driven precision design, delivery innovation, and the road to clinical translation.

It is argued that epigenetic editing is progressively establishing itself as a distinctive therapeutic modality characterized by durable efficacy and sequence-independent safety-reversibility as a theoretical safety mechanism has been validated preclinically, but the monitoring and intervention infrastructure required for its clinical implementation remains to be established.

Shiqi Chang, Di Lu, Yuyuan Jin et al. · 0 citations